LAVAL, QC, May 29, 2019 /CNW/ - Crescita Therapeutics
Inc. (TSX: CTX) (OTC US: CRRTF) (Crescita or the Company), a
Canadian commercial dermatology company with a portfolio of
non-prescription skincare products and prescription drug products
for the treatment and care of skin conditions, diseases and their
symptoms, announced today that it has entered into a consulting
agreement with Bristol Capital LTD. ("Bristol"), a leading investor
relations firm servicing Canadian and US microcap and small cap
companies across international markets, to provide investor
relations and communication services.
Bristol will provide investor
relations services to Crescita, including introductions to
Bristol's direct network of
investment professionals, coordination of public events and
proactive investor relations campaigns to increase Crescita's
exposure in the investment community.
Serge Verreault, Crescita's
President and CEO stated, "We are pleased to engage Bristol Capital
at this very opportune time of growth. We are focused on enhancing
our investor outreach to tell the Crescita story and look forward
to working with the Bristol team
in establishing excellence in our investor relations
initiatives. We chose Bristol Capital because of their great
reputation and extensive network with retail and institutional
investors and are confident they will quickly engage and grow our
stakeholder base."
The Company and Bristol act at
arm's length, and Bristol has no
present interest, directly or indirectly, in the Company or its
securities. The fees paid by the Company to Bristol are for its services only.
About Crescita Therapeutics Inc.
Crescita
(TSX: CTX and OTC US: CRRTF) is a publicly traded, Canadian
commercial dermatology company with a portfolio of non-prescription
skincare products and prescription drug products for the treatment
and care of skin conditions and diseases and their
symptoms. Crescita owns multiple proprietary drug delivery
platforms that support the development of patented formulations
that can facilitate the delivery of active drugs into or through
the skin. Please visit
www.crescitatherapeutics.com for additional
information.
www.bristolir.com
View original content to download
multimedia:http://www.prnewswire.com/news-releases/crescita-therapeutics-engages-bristol-capital-to-provide-investor-relations-and-communications-services-300858186.html
SOURCE Crescita Therapeutics Inc.